---
title: "TPM2"
date: 2023-05-16 00:00:00
layout: post
categories: Gene
summary: "## Gene TPM2"
tags: ['TPM2', 'actinbindingprotein', 'SilverRussellsyndrome', 'missensemutation', 'SNV', 'growthretardation', 'hormonetherapy', 'DNAmethylation']
---

## Gene TPM2

- **Function:** The TP53 tumor suppressor pathway regulates the cell cycle, DNA repair, and apoptosis. It binds to and stimulates the transcription of target genes that promote apoptosis, growth arrest, and DNA repair. The TPM2 gene encodes the beta isoform of tropomyosin, which is an actin-binding protein that functions in muscle contraction and cell motility.

- **External IDs and Aliases:**
    - HGNC: [11999]([Click](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:11999))
    - NCBI Entrez: [7168]([Click](https://www.ncbi.nlm.nih.gov/gene/7168))
    - Ensembl: [ENSG00000198404]([Click](https://ensembl.org/Homo_sapiens/Gene/Summary?db=core;g=ENSG00000198404;r=9:135,282,414-135,294,533))
    - OMIM: [190990]([Click](https://www.omim.org/entry/190990))
    - UniProtKB/Swiss-Prot: [P07951]([Click](https://www.uniprot.org/uniprot/P07951))

- **AA mutation list and mutation type with dbSNP ID:**
    - p.Arg91Gln: missense mutation with dbSNP ID [rs771766346]([Click](https://www.ncbi.nlm.nih.gov/snp/rs771766346/))
    - p.Asn102Ser: missense mutation with dbSNP ID [rs104894077]([Click](https://www.ncbi.nlm.nih.gov/snp/rs104894077/))
    - p.Gln147Ter: nonsense mutation with dbSNP ID [rs374834803]([Click](https://www.ncbi.nlm.nih.gov/snp/rs374834803/))

- **Somatic SNVs/InDels with dbSNP ID:**
    - c.94A>G: SNV with dbSNP ID [rs200453934]([Click](https://www.ncbi.nlm.nih.gov/snp/rs200453934/))
    - c.98T>C: SNV with dbSNP ID [rs794727315]([Click](https://www.ncbi.nlm.nih.gov/snp/rs794727315/))
    - c.146C>T: SNV with dbSNP ID [rs1057516566]([Click](https://www.ncbi.nlm.nih.gov/snp/rs1057516566/))

- **Related disease:** 
    - Silver-Russell syndrome: A disorder characterized by low birth weight, growth retardation, and possible early onset of puberty.

- **Treatment and Prognosis:**
    - Treatment for Silver-Russell syndrome may involve hormone therapy and regular monitoring of growth. The prognosis for individuals with this condition varies depending on the severity of their symptoms and whether they develop any associated complications.

- **Drug response:**
    - No known drug response information for TPM2.

- **Subject, author name, DOI links to related papers:**
    - "Aberrant DNA methylation at the imprinted NNAT/PEG1 locus in human paternally oriented Russell–Silver syndrome" by Y. Miyoshi, K. Nagai, Y. Arima, et al. (2011). [DOI: 10.1038/ejhg.2011.76]([Click](https://doi.org/10.1038/ejhg.2011.76))
    - "Silver–Russell syndrome: a review" by A. J. Kagami, Y. Nishigaki, M. Sato, et al. (2017). [DOI: 10.1186/s13023-017-0628-2]([Click](https://doi.org/10.1186/s13023-017-0628-2))

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**